Jenscare Scientific Co., Ltd. provided its monthly return for January 2026, showing no changes in both issued share capital and total authorized capital compared to the end of December 2025. The authorized share capital remained at RMB 417,167,290, comprising 310,306,209 H shares and 106,861,081 unlisted shares.

According to the announcement, the total issued H shares stood at 310,306,209, while the total unlisted shares were 106,861,081 as of January 31, 2026. No share options, warrants, convertible instruments, or other arrangements were reported. The publicly listed H shares confirm compliance with the public float requirement of 17.32%, without any issue regarding float sufficiency.

The monthly return was submitted on February 5, 2026, by the joint company secretary, and no further share movements or updates were disclosed within the report.